Zevia’s (NYSE:ZVIA) Q2 CY2026 Sales Beat Estimates, Next Quarter’s Sales Guidance is Optimistic

Zevia (NYSE:ZVIA) reported Q2 CY2026 revenue of $45M, up 1.1% year over year and above Wall Street estimates. Management guided next-quarter revenue near $45M, about 2.2% above analyst forecasts. GAAP EPS loss was $0.04, $0.01 better than consensus. Free cash flow was $2.19M and turned positive.

Original reporting
Published Aug 5, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 9:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Zevia’s (NYSE:ZVIA) Q2 CY2026 Sales Beat Estimates, Next Quarter’s Sales Guidance is Optimistic — source image
Decision brief

The 30-second read

$ZVIABullishMed
01

Why it matters

Q2 revenue beat and a next-quarter revenue guide above consensus are actionable for traders managing near-term expectations, but the immediate 2.3% stock drop suggests investors weighed other guidance items (notably full-year revenue) and/or cash-flow durability.

02

Market read

This is a guidance-driven earnings update with specific revenue and EPS figures, plus a noted immediate negative tape reaction despite the beat.

03

What to watch

Free cash flow is small in absolute terms ($2.19M in Q2) and the article notes trailing-12-month revenue has been flat versus three years ago, which can cap multiple expansion.

Relevance 7/10Novelty 6/10Timing: after-hours/pre-market positioning following Q2 results and next-quarter guidance

Background

Zevia is a better-for-you beverage company focused on soda, with additional energy drink and tea offerings.

Company-level read

Ticker impact

$ZVIABullishMedium confidence
Context

Zevia reported Q2 CY2026 revenue of $45M, beat estimates, and guided next-quarter revenue to about $45M, 2.2% above consensus.

Expected impact

Likely supports a near-term re-rating attempt, but follow-through depends on whether investors focus on the revenue guide versus other misses (full-year revenue guidance).

Evidence & confidence

The article provides specific Q2 results, next-quarter revenue guidance, and notes immediate post-results downside, implying mixed market interpretation rather than a clean upside reaction.

Market effects

Signals modest demand resilience for a better-for-you beverage niche, but does not change broader sector fundamentals.

No specific regional impact described beyond US-listed consumer staples sentiment.

No global macro or international supply-chain developments mentioned.

Counterpoint

The guidance optimism may be offset by weaker full-year revenue guidance and limited free-cash-flow scale, so the market may be discounting sustainability.

Key entities

  • Zevia

    NYSE-listed beverage company reporting Q2 CY2026 results and providing next-quarter revenue and EBITDA-related guidance.

Related articles

$ZVIAMedAI 9/10

Zevia (ZVIA) Q2 2026 Earnings Call Transcript

Zevia PBC (ZVIA) reported Q2 2026 net sales of $45.0 million, up 1.1% on pricing actions, with adjusted EBITDA of $0.5 million. Net loss was $2.9 million. Q3 guidance calls for net sales of $44 million to $46 million and negative adjusted EBITDA of $3.0 million to $3.5 million, with full-year sales of $170 million to $175 million.

$ZVIAMed

Zevia PBC Q2 Earnings Call Highlights

Zevia PBC (ZVIA) reported Q2 expense details and cash of about $28.5M plus an undrawn $20M revolver. Management highlighted a push to expand singles, estimating up to ~$80M opportunity. Q3 guidance calls for net sales of $44M to $46M and adjusted EBITDA loss of $3M to $3.5M. Full-year 2026 net sales $170M to $175M and adjusted EBITDA loss $2M to $4M were maintained.

$ZVIAHigh

Zevia PBC (ZVIA): Results of Operations and Financial Condition

Zevia PBC (ZVIA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Zevia Announces Second Quarter 2026 Results Net Sales at the High End of Outlook; Adjusted EBITDA Exceeds Outlook LOS ANGELES – August 5, 2026 (BUSINESS WIRE) – Zevia PBC (“Zevia” or the “Company”) (NYSE: ZVIA), the Company bringing naturally delicious, zero sugar, c

$ZVIAMedAI 8/10

Zevia Appoints Brian Bousley as Chief Commercial Officer

Zevia PBC (NYSE: ZVIA) appointed Brian Bousley as Executive Vice President and Chief Commercial Officer, effective immediately. He will lead sales, distribution and category management, reporting to CEO Amy Taylor. Zevia said Bousley brings 25+ years in beverages, including CCO roles at Yerba Madre and prior leadership at Pabst Brewing and Red Bull.

$EQIXMedAI 8/10

Equinix Is Doubling Down on AI Data Centers. How to Play EQIX Stock Here

Equinix (EQIX) reported Q2 revenue of $2.63B, up 16% YoY, beating estimates. AFFO was $11.78/share, up 19% YoY. The company raised full-year guidance and unveiled a multi-year growth plan. EQIX stock has surged 34% over the past year and offers a 1.98% dividend yield. Analysts rate it a 'Strong Buy' with an average price target of $1,232.19.